Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children

Pediatrics

Volumn 129, Issue 1, 2012, Pages

  Hambidge, Simon J ^a,b,c,d   Ross, Colleen ^a   Glanz, Jason ^a,d   McClure, David ^a   Daley, Matthew F ^a,c   Xu, Stan ^a   Shoup, Jo Ann ^a   Narwaney, Komal ^a   Baggs, James ^e   Weintraub, Eric ^e   Gay, Charlene ^f   Nordin, James D ^g   Baxter, Roger ^a   Jacobsen, Steven J ^a   Irving, Stephanie ^h   Naleway, Allison ^a   Jackson, Lisa A ⁱ  

^a KAISER PERMANENTE   (United States)

^b DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^c University of Colorado Denver and Children s Hospital Colorado   (United States)

^d Food Science and Human Nutrition   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f HARVARD PILGRIM HEALTH CARE   (United States)

^g Health Partners Research Foundation   (United States)

^h MARSHFIELD CLINIC   (United States)

ⁱ GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Childhood immunization; Children and adolescents; Influenza vaccine; Sickle cell disease; Vaccines

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ARTICLE; CASE STUDY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; SICKLE CELL CRISIS;

EID: 84855275528     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1294     Document Type: Article

References (18)

1. Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD. Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med. 2010;38(suppl 4):S550-S556
2. Bundy DG, Strouse JJ, Casella JF, Miller MR. Burden of influenza-related hospitalizations among children with sickle cell disease. Pediatrics. 2010;125(2):234-243
3. Fiore AE, Shay DK, Broder K, et al Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009;58(RR-8):1-52
4. Hambidge SJ, Glanz JM, France EK, et al Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006;296(16):1990-1997 (Pubitemid 44631445)
5. Chen RT, Glasser JW, Rhodes PH, et al The Vaccine Safety Datalink Team. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics. 1997;99(6):765-773 (Pubitemid 27231345)
6. DeStefano F; Vaccine Safety Datalink Research Group. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf. 2001;10(5):403-406
7. Platt OS. The acute chest syndrome of sickle cell disease. N Engl J Med. 2000;342(25):1904-1907 (Pubitemid 30419057)
8. Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol. 1996;143(11):1165-1173 (Pubitemid 26158114)
9. Glanz JM, McClure DL, Xu S, et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006;59(8):808-818 (Pubitemid 43996937)
10. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years - United States 2010. MMWR Recomm Rep. 2010;58(51&52):1-4
11. France EK, Glanz JM, Xu S, et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med. 2004;158(11):1031-1036 (Pubitemid 39458490)
12. Bhatt P, Block SL, Toback SL, Ambrose CS. A prospective observational study of US inoffice pediatric influenza vaccination during the 2007 to 2009 influenza seasons: use and factors associated with increased vaccination rates. Clin Pediatr (Phila). 2010;49(10):954-963
13. Glezen WP, Glezen LS, Alcorn R. Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. Am J Dis Child. 1983;137(11):1095-1097 (Pubitemid 13021599)
14. Steinberg E, Overturf GD, Portnoy B, Powars DR, Boyer KM, Cherry JD. Serologic and clinical response of children with sickle cell disease to bivalent influenza A split virus vaccine. J Pediatr. 1978;92(5):823-825 (Pubitemid 8314621)
15. Souza AR, Braga JAP, de Paiva TM, Loggetto SR, Azevedo RS, Weckx LY. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia. Vaccine. 2010;28(4):1117-1120
16. Greene SK, Shi P, Dutta-Linn MM, et al. Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. Am J Prev Med. 2009;37(6):552-555
17. Kramarz P, Destefano F, Gargiullo PM, et al; Vaccine Safety Datalink team. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr. 2001;138(3):306-310 (Pubitemid 32207129)
18. Centers for Disease Control and Prevention. Recommendation of the Public Health Service Advisory Committee on Immunization Practices: Influenza vaccine. MMWR Morb Mortal Wkly Rep. 1978;27(32):285-292